Olympus announced the launch of its EndoClot offerings for use in gastrointestinal (GI) procedures in the Europe, Middle East and Africa (EMEA) region.
The EndoClot portfolio supports hemostasis and lifting in endoscopic submucosal dissection or resection in GI procedures. Olympus launched the EndoClot adhesive, the EndoClot polysaccharide hemostatic spray and the EndoClot submucosal injection solution.
EndoClot Plus developed the portfolio of GI solutions. The company expanded its distribution agreement with Olympus from the U.S. to EMEA in December 2022.